Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations
Abstract Background Theragnostic management, treatment according to precise pathological molecular targets, requests to unravel patients’ genotypes. We used targeted next-generation sequencing (NGS) or digital droplet polymerase chain reaction (ddPCR) to screen for somatic PIK3CA mutations on DNA ex...
Main Authors: | Pascal Brouillard, Matthieu J. Schlögel, Nassim Homayun Sepehr, Raphaël Helaers, Angela Queisser, Elodie Fastré, Simon Boutry, Sandra Schmitz, Philippe Clapuyt, Frank Hammer, Anne Dompmartin, Annamaria Weitz-Tuoretmaa, Jussi Laranne, Louise Pasquesoone, Catheline Vilain, Laurence M. Boon, Miikka Vikkula |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13023-021-01898-y |
Similar Items
-
KRAS-driven model of Gorham-Stout disease effectively treated with trametinib
by: Nassim Homayun-Sepehr, et al.
Published: (2021-08-01) -
Excalibur: A new ensemble method based on an optimal combination of aggregation tests for rare-variant association testing for sequencing data.
by: Simon Boutry, et al.
Published: (2023-09-01) -
A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations
by: Guillaume Canaud, et al.
Published: (2021-07-01) -
Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation
by: Ines Martinez-Corral, et al.
Published: (2020-06-01) -
CLOVES syndrome caused by mosaic mutation in the PIK3CA gene identified in fibroblasts
by: Magdalena Kłaniewska, et al.
Published: (2021-07-01)